CBUSCibus Inc. Class A Common Stock
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides…
Industry Peers
Biotechnology| Headline | Source | Time |
|---|---|---|
Older | ||
![]() Cibus Inc: Interoc Expands Rice Trade to 5 Traits, 36% Revenue Growth – Quarterly Update Report Download the Complete Report Here Cibus, Inc. (CBUS) Interoc Expands Rice Pipeline to Five Traits; Platform Revenue and Cost Discipline Advance as LATAM Launch Moves to 2028 Key Takeaways: Rice commercialization advanced as Interoc testing began and the relationship expanded from two to five traits, although initial LATAM launch timing moved to 2028. Sustainable Ingredients […] The post Cibus Inc: Interoc Expands Rice Trade to 5 Traits, 36% Revenue Growth – Quarterly Update Report appeared first | EExec Edge | |
Cibus Inc: Interoc Expands Rice Trade to 5 Traits, 36% Revenue Growth – Downloadable Quarterly Update Report Cibus, Inc. (CBUS) Interoc Expands Rice Pipeline to Five Traits; Platform Revenue and Cost Discipline Advance as LATAM Launch Moves to 2028 Read Exec Edge’s Initiation on Cibus, Inc. Here Subscribe to our Weekly Newsletter to Receive All Research Contact: Executives-Edge.com [email protected] The post Cibus Inc: Interoc Expands Rice Trade to 5 Traits, 36% Revenue Growth – Downloadable Quarterly Update Report appeared first on ExecEdge. | EExec Edge | |
![]() Cibus, Inc. Q2 2026 Earnings Call Summary Moby summary of Cibus, Inc.'s Q2 2026 earnings call | ||
Cibus Inc (CBUS) (Q2 2026) Earnings Call Highlights: Strategic Pivot to Trait Pipeline Model ... Despite a delayed rice launch and cash runway concerns, Cibus expands partnerships and advances regulatory approvals across key markets. | ||
![]() Cibus Q2 Earnings Call Highlights Cibus (NASDAQ:CBUS) reported second-quarter 2026 revenue of $1.0 million, compared with $0.9 million a year earlier, as the agricultural biotechnology company advanced its Sustainable Ingredients program and updated the expected timing of its initial rice launch in Latin America. For the first six | ||
![]() Cibus (CBUS) Reports Q2 Loss, Misses Revenue Estimates Cibus (CBUS) delivered earnings and revenue surprises of -11.54% and -29.50%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock? | ||
Alico (ALCO) Surpasses Q3 Earnings and Revenue Estimates Alico (ALCO) delivered earnings and revenue surprises of +139.73% and +247.69%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock? | ||
Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection Download the Complete Report Here Cibus, Inc. (CBUS) Rice Royalty Conversion, Precision-Breeding Platform, and BioFragrance Scale-Up Support Commercial Inflection CBUS is an asset-light precision-breeding platform that develops productivity traits for seed-company partners, rather than owning seed production, distribution or farmer relationships. RTDS and the Trait Machine process are designed to edit elite customer germplasm and […] The post Cibus Inc’s Precision-Breeding Platform and BioFragra | EExec Edge | |
Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection – Downloadable Initiation Report Cibus, Inc. (CBUS) Rice Royalty Conversion, Precision-Breeding Platform, and BioFragrance Scale-Up Support Commercial Inflection Subscribe to our Weekly Newsletter to Receive All Research Contact: Executives-Edge.com [email protected] The post Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection – Downloadable Initiation Report appeared first on ExecEdge. | EExec Edge | |
Cibus (CBUS) Welcomes Landmark EU Crop Breeding Decision Cibus, Inc. (NASDAQ:CBUS) is one of the 10 Fastest Growing Tech Penny Stocks to Buy. On June 17, 2026, Cibus, Inc. (NASDAQ:CBUS) welcomed a landmark European Union decision under which crops improved without adding foreign DNA will be treated like conventionally bred crops rather than transgenic GMOs. Cibus said the decision opens a path for […] | IInsider Monkey | |



